Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury

• Published in: Scientific reports Vol. 7; no. 1; pp. 3846 - 15
• Main Authors: Lutton, Evan M., Razmpour, Roshanak, Andrews, Allison M., Cannella, Lee Anne, Son, Young-Jin, Shuvaev, Vladimir V., Muzykantov, Vladimir R., Ramirez, Servio H.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 19.06.2017; Nature Publishing Group; Nature Portfolio
• Subjects: 14/63; 14/69; 631/378/1341; 631/378/1689/364; 96/1; Animals; Antioxidants; Blood-brain barrier; Blood-Brain Barrier - metabolism; Brain Injuries, Traumatic - drug therapy; Brain Injuries, Traumatic - metabolism; Brain Injuries, Traumatic - pathology; Catalase; Catalase - administration & dosage; Cortex; Detoxification; Endothelial Cells - metabolism; Humanities and Social Sciences; Hydrogen Peroxide - metabolism; Inflammation; Intercellular adhesion molecule 1; Intercellular Adhesion Molecule-1 - metabolism; Membrane permeability; Mice; Microglia; Microglia - metabolism; multidisciplinary; Neuroglia - metabolism; Neuropathology; Oxidative Stress; Permeability; Protective Agents - administration & dosage; Reactive oxygen species; Reactive Oxygen Species - metabolism; Science; Science (multidisciplinary); Traumatic brain injury; Tyrosine - analogs & derivatives; Tyrosine - metabolism
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-017-03309-4

Traumatic brain injury (TBI) contributes to one third of injury related deaths in the US. Treatment strategies for TBI are supportive, and the pathophysiology is not fully understood. Secondary mechanisms of injury in TBI, such as oxidative stress and inflammation, are points at which intervention may reduce neuropathology. Evidence suggests that reactive oxygen species (ROS) propagate blood-brain barrier (BBB) hyperpermeability and inflammation following TBI. We hypothesized that targeted detoxification of ROS may improve the pathological outcomes of TBI. Following TBI, endothelial activation results in a time dependent increase in vascular expression of ICAM-1. We conjugated catalase to anti-ICAM-1 antibodies and administered the conjugate to 8 wk old C57BL/6J mice 30 min after moderate controlled cortical impact injury. Results indicate that catalase targeted to ICAM-1 reduces markers of oxidative stress, preserves BBB permeability, and attenuates neuropathological indices more effectively than non-targeted catalase and anti-ICAM-1 antibody alone. Furthermore, the study of microglia by two-photon microscopy revealed that anti-ICAM-1/catalase prevents the transition of microglia to an activated phenotype. These findings demonstrate the use of a targeted antioxidant enzyme to interfere with oxidative stress mechanisms in TBI and provide a proof-of-concept approach to improve acute TBI management that may also be applicable to other neuroinflammatory conditions.